Onderneming Rocket Pharmaceuticals, Inc.
Aandelen
RCKT
US77313F1066
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
22,68 USD | -1,35% | +6,38% | -24,32% |
16/05 | Transcript : Rocket Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM | |
10/05 | ROCKET PHARMACEUTICALS, INC. : UBS bevestigt koopadvies | ZM |
Vakgebied
Aantal werknemers: 268
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 04-01-18 |
Kinnari Patel
PSD | President | 45 | 04-01-18 |
Chief Tech/Sci/R&D Officer | 60 | 01-01-16 | |
Mayo Pujols
CTO | Chief Tech/Sci/R&D Officer | 55 | 27-07-22 |
David Southwell
BRD | Director/Board Member | 63 | 01-08-14 |
Brooks Rahmer
IRC | Investor Relations Contact | - | - |
Mark White
PRN | Corporate Officer/Principal | 57 | 04-04-23 |
Carlos Martin
PRN | Corporate Officer/Principal | - | - |
Isabel Carmona
HRO | Human Resources Officer | - | 07-09-21 |
Gayatri R. Rao
PRN | Corporate Officer/Principal | - | 01-05-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 04-01-18 |
Carsten Boess
BRD | Director/Board Member | 57 | 01-01-16 |
David Southwell
BRD | Director/Board Member | 63 | 01-08-14 |
Rod Wong
CHM | Chairman | 47 | 01-01-18 |
Director/Board Member | 47 | 01-01-18 | |
Gotham Makker
BRD | Director/Board Member | 52 | 04-01-18 |
Fady Malik
BRD | Director/Board Member | 60 | 10-03-22 |
Director/Board Member | 62 | 20-04-20 | |
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 04-01-18 |
R. Woods
BRD | Director/Board Member | 56 | 12/12 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 90 782 211 | 85 857 306 ( 94,58 %) | 0 | 94,58 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-24,32% | 2,06 mld. | |
+18,72% | 125 mld. | |
+14,19% | 108 mld. | |
-4,93% | 24,21 mld. | |
+3,23% | 22,78 mld. | |
-10,44% | 17,96 mld. | |
-41,74% | 16,43 mld. | |
-13,31% | 16,37 mld. | |
+2,44% | 13,58 mld. | |
+27,89% | 11,66 mld. |
- Beurs
- Aandelen
- Koers RCKT
- Onderneming Rocket Pharmaceuticals, Inc.